Covalon Receives FDA Approval for New Wound Dressing

Covalon Technologies announced that it has received FDA approval for its antimicrobial silver collagen wound dressing, ColActiveAg. Covalon is now in a position to launch ColActiveAg and will now begin to process orders for ColActiveAg. Covalon has an exclusive distribution agreement with Hartmann-Conco to distribute Covalon antimicrobial silver collagen wound dressings under the brand name ColActiveAg. The agreement provides Hartmann-Conco with exclusive distribution rights for the U.S.

()a href="http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=544703" target="_blank">CCNMatthews